Treatment Outcome and Associated Factors Among Cervical Cancer Patients Treated at Tikur Anbesa Specializsed Hospital Addis Ababa, Ethiopia a Retrospective Study
| dc.contributor.advisor | Gebreyohannis Tigistu (MSc) | |
| dc.contributor.author | Tarik Fikeraddis | |
| dc.date.accessioned | 2018-11-06T09:16:27Z | |
| dc.date.accessioned | 2023-11-06T08:51:07Z | |
| dc.date.available | 2018-11-06T09:16:27Z | |
| dc.date.available | 2023-11-06T08:51:07Z | |
| dc.date.issued | 2018-01 | |
| dc.description.abstract | INTRODUCTION: Cervical cancer is a common cancer of the female reproductive system,specifically the cervix of the uterus. Based on the global burden of cancer 2008 estimates, about 12.7million cancer cases and 7.6 million cancer deaths are estimated to have occurred. Among these 56% of the cases and 64% of the deaths occurred in the economically developing world. Ethiopia is one of the developing countries with 42 million female populations and 7000 new cases of cervical cancer with 5000 deaths every year. Despite this high prevalence of disease there is only one cancer treatment center at TikurAnbesa specialized hospital which provides surgery, chemotherapy and radiotherapy. The facility serve as a national referral facility for all regions associated with this most of the time it is congested with many patients waiting to be treated. OBJECTIVES: to asses treatment outcome of cervical cancer patients and associated factor among patients treated at Tikur Anbesa specialized hospital oncology unit. Methods and analysis: retrospective quantitative cross sectional study design was conducted using questions to collect data from medical chart of patient who were treated for the past 5 years. Data was analyzed by bivariate, multivariate logistic regressions using SPSS version 22computer software. Result: In this study the treatment outcome of cervical cancer patients was cured for 3.6% patients and recurrence occurred among 26.2 % of cervical patients and 70.2% were lost from follow up. In multi logistic regression cervical patients those with stage 3b were 0.021 times {AOR=0.012; 95% CI (0.001-0.23)}, less likely to be cured compared to those have clinical stage 2A. Cancer patients those have positive result of pelvic node were 0.03times {AOR=0.001; 95% CI (0.001-0.92)} less likely to be cured compared to those have negative result of pelvic node. Cervical cancer patients with sero -positive HIV status were 2.8 times {AOR=2.8; 95% CI (2.14- 7.65)} more likely to have recurrence of disease compared to those with sero -negative HIV status. Conclusion and recommendation: The study revealed that there were a relatively low number patients cured from cervical cancer, slightly high number of recurrence of disease occurred and high number patients lost to follow up. There is a need to design treatment outcome improving intervention plan and implementation. | en_US |
| dc.identifier.uri | http://etd.aau.edu.et/handle/123456789/13801 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Addis Ababa University | en_US |
| dc.subject | Treatment outcome, cervical cancer, associated factor | en_US |
| dc.title | Treatment Outcome and Associated Factors Among Cervical Cancer Patients Treated at Tikur Anbesa Specializsed Hospital Addis Ababa, Ethiopia a Retrospective Study | en_US |
| dc.type | Thesis | en_US |